CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
prednisone in symptomatic bone-only metastatic castration-resistant prostate cancer (mCRPC)Open-label, randomized phase II trial in ...
Phase 2
Milano, Italy and 15 other locations
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Milan, Italy and 50 other locations
The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's...
Phase 3
Milan, Italy and 30 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Milan, Italy and 131 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Milan, Italy and 321 other locations
of ADT +/- darolutamide in castration-naïve de novo metastatic prostate cancer patients with vulnerable functional ability who have...
Phase 3
Milano, Italy and 89 other locations
second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate...
Phase 3
Milan, Italy and 235 other locations
compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...
Phase 3
Milan, Lombardy, Italy and 279 other locations
This is a phase III, randomized, open-label, multi-center study to assess the efficacy of treatment intensification with docetaxel plus apalutamide a...
Phase 3
Milan, Italy and 55 other locations
Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...
Phase 3
Milan, Italy and 51 other locations
Clinical trials
Research sites
Resources
Legal